Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: Staphylococcus aureus is among the leading causes of community-acquired as well as healthcare-associated and hospital-acquired bacteremia and endocarditis. The purpose of this review was to analyze most recent data relevant to the clinical management of S. aureus bacteremia (SAB) and endocarditis. RECENT FINDINGS: Population-based studies have shown that the incidence of SAB has not decreased in the last years and that healthcare-associated and nosocomial cases continue to account for at least half of SAB. In some areas where methicillin-resistant S. aureus (MRSA) now has become common, MRSA strains with reduced vancomycin susceptibility may have emerged and account for a significant proportion. These strains increase the likelihood of treatment failures, though overall outcomes may often be similarly poor in drug-susceptible S. aureus, which must not be neglected as a pathogen causing potentially lethal infection. Many aspects of drug therapy such as continuous versus intermittent infusion of antibiotics or combination therapy continue to be discussed controversially. Few major progresses in the clinical management have been made in the last few years, but there is evidence that the case fatality can be modestly reduced by efforts focussed on sustained high-quality clinical management. SUMMARY: SAB remains a serious, potentially lethal infection, which is too often nosocomial and healthcare-associated. A threat has been the increasing drug resistance of S. aureus seen in many parts of the world and spreading among community isolates. Improved outcomes with new drugs have not been shown convincingly. Large clinical trials assessing the benefits of combination therapies are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murdoch, D. R. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.603 · Cited by 2,362
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
Lalani, T., Cabell, C. H., Benjamin, D. K., Lasca, O., Naber, C., Fowler, V. G., Corey, G. R., Chu, V. H., Fenely, M., Pachirat, O., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.864488 · Cited by 308
Health Care–Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition
Benito, N., Miró, J. M., de Lazzari, E., Cabell, C. H., del Río, A., Altclas, J., Commerford, P., Delahaye, F., Dragulescu, S., Giamarellou, H., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00004 · Cited by 277
Cooper, H. A., Thompson, E. C., Laureno, R., Fuisz, A., Mark, A. S., Lin, M., & Goldstein, S. A. (2009) · Circulation · doi:10.1161/circulationaha.108.834432 · Cited by 223
Khatib, R., Saeed, S., Sharma, M., Riederer, K., Fakih, M. G., & Johnson, L. B. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0096-0 · Cited by 156
Bae, I., Federspiel, J. J., Miró, J. M., Woods, C. W., Park, L., Rybak, M. J., Rude, T. H., Bradley, S., Bukovski, S., de la Maria, C. G., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/606027 · Cited by 122
LaPlante, K. L., & Woodmansee, S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00134-09 · Cited by 110
Simor, A. E., Gilbert, N. L., Gravel, D., Mulvey, M. R., Bryce, E., Loeb, M., Matlow, A., McGeer, A., Louie, L., Campbell, J., et al. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651313 · Cited by 87
Hughes, D. W., Frei, C. R., Maxwell, P. R., Green, K., Patterson, J. E., Crawford, G. E., & Lewis, J. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01232-08 · Cited by 52
Cited by
Tuchscherr, L., Medina, E., Hussain, M., Völker, W., Heitmann, V., Niemann, S., Holzinger, D., Roth, J., Proctor, R. A., Becker, K., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201000115 · Cited by 437
Kern, W. V., & Rieg, S. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.10.031 · Cited by 355
Self-citationKaasch, A. J., Barlow, G., Edgeworth, J. D., Fowler, V. G., Hellmich, M., Hopkins, S., Kern, W. V., Llewelyn, M. J., Rieg, S., Rodriguez-Baño, J., et al. (2014) · Journal of Infection · doi:10.1016/j.jinf.2013.10.015 · Cited by 277
Self-citationLandrum, M. L., Neumann, C., Cook, C., Chukwuma, U., Ellis, M. W., Hospenthal, D. R., & Murray, C. K. (2012) · JAMA · doi:10.1001/jama.2012.7139 · Cited by 228
Metadata
- Authors
- Kern, W. V.
- Venue
- Current Opinion in Infectious Diseases
- Published
- 2010-08
- Volume
- 23
- Issue
- 4
- Pages
- 346-358
- ISSN
- 0951-7375 (ISSN-L)
- OpenAlex
- W1971305074
- Cited by
- 102
- References
- 12
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.